Mohit Narang

Analysis of Common Eligibility Criteria of Randomized Controlled Trials in Newly Diagnosed Multiple Myeloma Patients and Extrapolating Outcomes

Jatin J. Shah, Rafat Abonour, Christina Gasparetto et al. · Clinical Lymphoma Myeloma & Leukemia · 2017 · 93 citations

Medicine, Internal Medicine, Oncology +11

Daratumumab, bortezomib, cyclophosphamide and dexamethasone in newly diagnosed and relapsed multiple myeloma: <scp>LYRA</scp> study

Habte Yimer, Jason M. Melear, Edward A. Faber et al. · British Journal of Haematology · 2019 · 67 citations · Full text

Medicine, Pharmacotherapy, Cancer Pharmacology +16

Chikungunya outbreak in Delhi, India, 2016: report on coinfection status and comorbid conditions in patients

Navjot Kaur, Jaspreet Jain, Ankit Kumar et al. · New Microbes and New Infections · 2017 · 56 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Recognition of early mortality in multiple myeloma by a prediction matrix

Howard R. Terebelo, Shankar Srinivasan, Mohit Narang et al. · American Journal of Hematology · 2017 · 47 citations · Full text

Medicine, Hematology, Oncology +15

Impact of post-transplantation maintenance therapy on health-related quality of life in patients with multiple myeloma: data from the Connect® MM Registry

Rafat Abonour, Lynne I. Wagner, Brian G.M. Durie et al. · Annals of Hematology · 2018 · 47 citations · Full text

Medicine, Internal Medicine, Oncology +16